<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>CytoCares | wechat-feeds</title><link>http://MzAxNjQ3NjI4MA.favicon.privacyhide.com/favicon.ico</link><description>为您传递细胞治疗相关行业信息与技术进展，共同促进国内免疫治疗技术发展与行业繁荣。</description><managingEditor> (hellodword)</managingEditor><pubDate>Thu, 04 Feb 2021 20:35:46 +0800</pubDate><image><url>http://MzAxNjQ3NjI4MA.favicon.privacyhide.com/favicon.ico</url><title>CytoCares | wechat-feeds</title><link>http://MzAxNjQ3NjI4MA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>2021年最值得关注的抗体药物</title><link>https://mp.weixin.qq.com/s/ENPh2m_Nn1xRCy0C-iu46g</link><description></description><content:encoded><![CDATA[2021年最值得关注的抗体药物]]></content:encoded><pubDate>Thu, 04 Feb 2021 18:34:39 +0800</pubDate></item><item><title>抗体药物动态-20210204</title><link>https://mp.weixin.qq.com/s/E1LtK_WScK6djer4rUFzog</link><description></description><content:encoded><![CDATA[抗体药物动态-20210204]]></content:encoded><pubDate>Thu, 04 Feb 2021 18:34:39 +0800</pubDate></item><item><title>IL-36：炎症与肿瘤</title><link>https://mp.weixin.qq.com/s/mE0LD5IEqVd4mFkNT9ThNA</link><description></description><content:encoded><![CDATA[IL-36：炎症与肿瘤]]></content:encoded><pubDate>Wed, 03 Feb 2021 19:08:42 +0800</pubDate></item><item><title>抗体+PROTAC的星星之火是否会有燎原之势？</title><link>https://mp.weixin.qq.com/s/CAM76d4Bi-AUOeCWLcMKww</link><description></description><content:encoded><![CDATA[抗体+PROTAC的星星之火是否会有燎原之势？]]></content:encoded><pubDate>Wed, 03 Feb 2021 19:08:42 +0800</pubDate></item><item><title>肿瘤干细胞与免疫细胞的相互作用</title><link>https://mp.weixin.qq.com/s/ekVzDlZKm3jm-PPYRwFPVA</link><description></description><content:encoded><![CDATA[肿瘤干细胞与免疫细胞的相互作用]]></content:encoded><pubDate>Tue, 02 Feb 2021 18:50:20 +0800</pubDate></item><item><title>抗体药物动态-20210202</title><link>https://mp.weixin.qq.com/s/MoFxYDaAYcIdb1oDg-IP2A</link><description></description><content:encoded><![CDATA[抗体药物动态-20210202]]></content:encoded><pubDate>Tue, 02 Feb 2021 18:50:20 +0800</pubDate></item><item><title>CD33靶向双特异性抗体的开发现状</title><link>https://mp.weixin.qq.com/s/L53S9jyPDMlnO9bYKQrwfQ</link><description></description><content:encoded><![CDATA[CD33靶向双特异性抗体的开发现状]]></content:encoded><pubDate>Mon, 01 Feb 2021 18:04:24 +0800</pubDate></item><item><title>抗体药物动态-20210201</title><link>https://mp.weixin.qq.com/s/zFb-mgezQgrBiJBtz9cCpQ</link><description></description><content:encoded><![CDATA[抗体药物动态-20210201]]></content:encoded><pubDate>Mon, 01 Feb 2021 18:04:24 +0800</pubDate></item><item><title>抗体药物动态-20210129</title><link>https://mp.weixin.qq.com/s/jHGxwAUJHHu1V_qAtmt_oQ</link><description></description><content:encoded><![CDATA[抗体药物动态-20210129]]></content:encoded><pubDate>Fri, 29 Jan 2021 18:56:48 +0800</pubDate></item><item><title>常见非IgG样双抗</title><link>https://mp.weixin.qq.com/s/-AFCnGiU4lLjNossw7Xlfg</link><description></description><content:encoded><![CDATA[常见非IgG样双抗]]></content:encoded><pubDate>Thu, 28 Jan 2021 18:11:02 +0800</pubDate></item><item><title>抗体药物动态-20210128</title><link>https://mp.weixin.qq.com/s/v1qFjVFLzHsa_vNQdoF2VA</link><description></description><content:encoded><![CDATA[抗体药物动态-20210128]]></content:encoded><pubDate>Thu, 28 Jan 2021 18:11:02 +0800</pubDate></item><item><title>是否打疫苗？打了疫苗后就不会得新冠了吗？</title><link>https://mp.weixin.qq.com/s/6gSc9i9lSgUVBqjShdLMvw</link><description></description><content:encoded><![CDATA[是否打疫苗？打了疫苗后就不会得新冠了吗？]]></content:encoded><pubDate>Wed, 27 Jan 2021 18:15:14 +0800</pubDate></item><item><title>IL-2和IL-15的肿瘤免疫中的调节作用及其应用前景</title><link>https://mp.weixin.qq.com/s/QPhCL_vMYivu47UijAKctw</link><description></description><content:encoded><![CDATA[IL-2和IL-15的肿瘤免疫中的调节作用及其应用前景]]></content:encoded><pubDate>Tue, 26 Jan 2021 18:29:09 +0800</pubDate></item><item><title>抗体药物动态-20210126</title><link>https://mp.weixin.qq.com/s/ec_RZIyZjgL0QQw6kARbjw</link><description></description><content:encoded><![CDATA[抗体药物动态-20210126]]></content:encoded><pubDate>Tue, 26 Jan 2021 18:29:09 +0800</pubDate></item><item><title>“生物导弹”ADC 药物迎来黄金时代，挑战下一个千亿市场！</title><link>https://mp.weixin.qq.com/s/SuOErnn7nkw60f4_IctbAA</link><description></description><content:encoded><![CDATA[“生物导弹”ADC 药物迎来黄金时代，挑战下一个千亿市场！]]></content:encoded><pubDate>Mon, 25 Jan 2021 18:31:25 +0800</pubDate></item><item><title>靶向新生儿Fc受体：FcRn</title><link>https://mp.weixin.qq.com/s/0P054Crl1VSw9Rhn_dHN1g</link><description></description><content:encoded><![CDATA[靶向新生儿Fc受体：FcRn]]></content:encoded><pubDate>Fri, 22 Jan 2021 18:41:03 +0800</pubDate></item><item><title>抗体药物动态-20210122</title><link>https://mp.weixin.qq.com/s/9ngqBUUHzlTiwirXXtS2Fg</link><description></description><content:encoded><![CDATA[抗体药物动态-20210122]]></content:encoded><pubDate>Fri, 22 Jan 2021 18:41:03 +0800</pubDate></item></channel></rss>